2 (non-insulin-dependent) diabetes mellitus who changed therapy from an oral hypoglycaemic agent (OHA) to insulin and … consecutively recruited patients with type 2 diabetes mellitus who were switched from an OHA to insulin therapy (group 1) were … for switching to insulin therapy. Main Outcome Measures and Results: At baseline, various QOL ratings were higher among …

progression in patients with type 2 (non-insulin-dependent) diabetes mellitus uncontrolled by diet and exercise. The model is …

Background: In clinical trials, patients have expressed greater satisfaction with inhaled human insulin (EXUBERA …(R), Pfizer) than with injectable insulin. No studies to date have attempted to quantify the strength of preferences for these … treatment with inhaled human insulin compared with injectable insulin. Study design: A patient preference study. Methods …

1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus and 36 520 age- and gender-matched controls …

nasal insulin. Objective: To analyse direct costs of type 1 diabetes prevention therapy with nasal insulin as it is now … _ $US1.1; 2002 values). Subsequently, the costs rose only as a result of the increased use of insulin as the children grew … prevention with nasal insulin are low when compared with estimates of the annual healthcare costs of type 1 diabetes. This study …

initiation of insulin therapy in patients with type 2 diabetes mellitus in 2 settings in The Netherlands. Design: Retrospective … transferred to insulin therapy in 1993 in both settings. Intervention: Initiation and monitoring of insulin therapy in patients … glycosylated hemoglobin (HbA1c) values and fasting blood glucose levels, and direct healthcare costs of insulin therapy. Costs were …

obese patients using orlistat in addition to standard diabetes therapy (i.e., a sulphonlyurea, metformin or insulin) and …